Prestige Consumer Healthcare Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Ronald Lombardi
- Full Time Employees
- 890
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 660 White Plains Road Tarrytown NY United States of America 10591
- IPO Date
- Feb 10, 2005
- CIK
- 0001295947
- Website
- prestigebrands.com
- Similar Companies
- Business
- Prestige Consumer Healthcare Inc. (NYSE: PBH) develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products and select household cleaning items to retailers across North America and select international markets; its portfolio spans digestive care including Beano, Phazyme, Tagamet, Fleet, and Bacid; eye, ear, nose, and throat remedies such as Clear Eyes, Chloraseptic, Luden's throat lozenges, Debrox, NasalCrom, and Murine; pain relief options like BC Powder and Goody's Headache Powder; oral care products including Efferdent and DenTek; pediatric care with PediaCare, Little Remedies, Boudreaux's Butt Paste, and Nix lice treatments; skin care featuring Compound W wart removal; sleep aids; women's health comprising Monistat yeast infection treatments and Summer's Eve feminine hygiene; and household cleaners such as Spic and Span and Comet. Founded in 1996 through the merger of Medtech Products, Prestige Brands International, and Spic and Span, the company is headquartered in Tarrytown, New York, with a manufacturing facility in Lynchburg, Virginia, and additional operations in the United States, Canada, Australia, and other regions. In fiscal 2026, Prestige entered a definitive agreement to acquire Pillar5 Pharma Inc., a sterile ophthalmic manufacturer and key supplier for Clear Eyes, from Anjac SAS for approximately $150 million in a cash-funded deal expected to close in the third fiscal quarter, enhancing vertical integration, securing 90% in-house manufacturing for eye care and related products, and enabling expansion into OTC men's health via Anjac's men's grooming capabilities including hair loss, skin care, and stress management innovations; the transaction remains roughly EPS-neutral while bolstering supply chain resilience amid robust Clear Eyes demand.
Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity
Fifth Third Bancorp Purchases 28,699 Shares of Prestige Consumer Healthcare Inc. $PBH
Bessemer Group Inc. Acquires 64,760 Shares of Prestige Consumer Healthcare Inc. $PBH
John Rogers Increases Stake in Prestige Consumer Healthcare Inc
Is the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock?
Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date
Alphabet Joined the Dow and Became a Top Holding in Berkshire Hathaway's Portfolio. But This Stock Could Be an Even Better Buy.
Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes
Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, HBSS Investigating
Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, Hagens Berman Investigating
Prestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026
Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH